- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Endometrial Biopsy in Canada
Total 132 results
-
Leiden University Medical CenterCanadian Institutes of Health Research (CIHR); AstraZeneca; National Cancer Institute... and other collaboratorsRecruitingEndometrial CancerNetherlands, Canada, France, United Kingdom
-
Canadian Cancer Trials GroupCanadian Cancer Clinical Trials NetworkRecruitingEndometrial CancerCanada, Australia, Netherlands
-
McGill UniversityRecruiting
-
InSightecRecruitingGlioma | Glioblastoma | Liquid BiopsyUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Endometrial Carcinoma | Stage III Uterine Corpus Cancer AJCC v8 | Stage IV Uterine Corpus Cancer AJCC v8 | Advanced Endometrial Carcinoma | Metastatic Endometrial CarcinomaUnited States, Canada
-
NCIC Clinical Trials GroupAriad PharmaceuticalsCompletedEndometrial CancerCanada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Norway, Canada, Australia, Japan
-
Novartis PharmaceuticalsCompletedBreast Cancer | Ovarian Cancer | Colon Cancer | Endometrium CancerCanada, Netherlands, Spain, United States
-
CASI Pharmaceuticals, Inc.CompletedOvarian Cancer | Endometrial CancerCanada
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupCompletedStage IA Uterine Corpus Cancer AJCC v7 | Stage IB Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus... and other conditionsUnited States, Canada, Hong Kong
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Canada
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingRecurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Endometrial Serous Adenocarcinoma | Recurrent Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell... and other conditionsUnited States, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedEndometrial CancerUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Recurrent Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer AJCC v7 | Stage IVA Uterine Corpus Cancer AJCC v7 | Stage IVB Uterine Corpus Cancer AJCC v7 | Endometrial Adenosquamous... and other conditionsUnited States, Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)CompletedSarcoma | Endometrial CancerCanada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Canada, Norway, United Kingdom, Australia
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Canada
-
European Organisation for Research and Treatment...NCIC Clinical Trials GroupCompletedSarcoma | Endometrial CancerFrance, Canada, Sweden, Spain, Belgium, Netherlands, Italy, United Kingdom, Poland, Switzerland
-
Women's Cancer Care Associates, LLCCompletedEndometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Stage IIIA Uterine Corpus Cancer | Stage IIIB Uterine Corpus Cancer | Stage IIIC Uterine Corpus Cancer | Stage IVA Uterine Corpus CancerUnited States, Canada
-
London Health Sciences CentreCompletedLymphoma | Kidney Cancer | Breast Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Endometrial CancerCanada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Canada
-
Hoffmann-La RocheRecruitingEndometrial CancerUnited States, Canada, Italy, Poland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedCervical Cancer | Endometrial CancerUnited States, Canada
-
Karyopharm Therapeutics IncGOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaboratorsRecruitingEndometrial CancerUnited States, Belgium, Spain, Israel, Australia, Italy, Georgia, Ireland, Greece, Slovakia, Canada, Hungary, Czechia, Germany
-
AEterna ZentarisCompletedEndometrial CancerUnited States, Spain, Canada, Ireland, Norway, Austria, Denmark, Israel, United Kingdom, Belgium, Finland, Romania, Czechia, Italy, Poland, Germany, Netherlands, Belarus, Bosnia and Herzegovina, Bulgaria, Russian Federation, Ukraine
-
R-PharmTerminatedEndometrial CancerBrazil, Czech Republic, Italy, Mexico, Russian Federation, Sweden, United Kingdom, United States, Spain, Canada, Denmark, France, Peru, Belgium, Hungary, Norway, Argentina, Australia, Greece
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingEndometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Stage IV Uterine Corpus Cancer AJCC v8 | Endometrial Adenocarcinoma | Endometrioid AdenocarcinomaUnited States, Canada
-
National Cancer Institute (NCI)NRG OncologyCompletedCervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Cervical Small Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Endometrial Clear Cell Carcinoma | Stage III Endometrial Carcinoma | Cervical... and other conditionsUnited States, Korea, Republic of, Japan, Canada
-
ARCAGY/ GINECO GROUPGlaxoSmithKlineRecruitingEndometrial CancerFrance, Spain, Singapore, Australia, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Endometrial CancerUnited States, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Endometrial CancerUnited States, Canada
-
National Cancer Institute (NCI)CompletedUterine Carcinosarcoma | Recurrent Uterine Corpus Carcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Stage IVA Uterine Corpus Cancer AJCC v7 | Stage IVB Uterine Corpus Cancer AJCC v7 | Uterine Corpus CarcinosarcomaUnited States, Canada
-
Karyopharm Therapeutics IncBelgium and Luxembourg Gynaecological Oncology Group; North-Eastern German... and other collaboratorsActive, not recruitingEndometrial CancerUnited States, China, Israel, Spain, Belgium, Germany, Greece, Czechia, Italy, Canada
-
Kartos Therapeutics, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingEndometrial CancerUnited States, Austria, Spain, Israel, Denmark, Sweden, Slovenia, Finland, Georgia, Italy, Romania, Poland, Canada, Estonia, Hungary, Lithuania, Norway
-
Merck Sharp & Dohme LLCGOG Foundation; European Network for Gynaecological Oncological Trial groups(ENGOT)RecruitingEndometrial CancerPoland, Canada, Australia, Israel, Korea, Republic of, United States, Spain, Chile, France, Puerto Rico, Greece, Netherlands, Norway, Singapore, Switzerland, Argentina, Austria, Belgium, Czechia, Denmark, Finland, Malaysia, Sweden, Italy and more
-
Merck Sharp & Dohme LLCRecruitingSolid Tumor | Endometrial Cancer | Cutaneous Squamous Cell CarcinomaCanada, Australia, Taiwan, Malaysia, United States, Netherlands, Turkey, France
-
Cook Group IncorporatedTerminatedUterine Neoplasms | Polycystic Ovary Syndrome | Endometrial Neoplasms | MenorrhagiaPanama
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
McGill UniversityUniversity of Ottawa; Canadian Cancer Society (CCS); Sir Mortimer B. Davis -... and other collaboratorsCompletedUterine Cervical Neoplasms | Breast Neoplasms | Ovarian Neoplasms | Endometrial NeoplasmsCanada
-
Tesaro, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingNeoplasmsUnited States, Canada, Netherlands, Spain, Finland, Belgium, Germany, Israel, Denmark, Sweden, United Kingdom, Poland, Hungary, Norway, Italy, Greece, Czechia, Ukraine, Belarus, Turkey
-
AstraZenecaRecruitingBreast Cancer | Ovarian Cancer | Endometrial Cancer | Biliary Tract CarcinomaUnited States, Spain, Australia, United Kingdom, Korea, Republic of, Belgium, Canada, China, Japan, Taiwan, Thailand, Hungary, Poland, Netherlands
-
PfizerTerminatedEndometrial NeoplasmsUnited States, Canada, Spain, United Kingdom, Japan, Russian Federation, Poland, Australia
-
Lawson Health Research InstituteActive, not recruitingCarcinosarcoma | Endometrioid Adenocarcinoma | Clear Cell Carcinoma | Serous Carcinoma | Dedifferentiated CarcinomaCanada
-
University Health Network, TorontoSunnybrook Health Sciences Centre; University of Toronto; Hamilton Health Sciences... and other collaboratorsActive, not recruitingUniversal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer (LS2)Colorectal Neoplasms | Ovarian Neoplasms | Lynch Syndrome | Endometrial NeoplasmsCanada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedCervical Cancer | Endometrial Cancer | Radiation Toxicity | Perioperative/Postoperative Complications | Gastrointestinal Complications | Urinary Complications | Urinary Tract ToxicityUnited States, Canada, Singapore, Hong Kong
-
Millennium Pharmaceuticals, Inc.European Network of Translational Research in Ovarian Cancer - EUTROC; European...CompletedEndometrial NeoplasmsUnited States, Canada, Netherlands, Spain, Belgium, United Kingdom, Italy, Australia, Germany, Norway
-
European Organisation for Research and Treatment...NCIC Clinical Trials GroupCompletedSarcoma | Kidney Cancer | Ovarian Cancer | Endometrial Cancer | PheochromocytomaFrance, Canada, Switzerland, Denmark, Belgium, Netherlands, United Kingdom, Germany, Italy, Slovakia, Spain, Portugal, Austria
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
TheratechnologiesPPD; Syneos Health; Windtree Therapeutics; Innovaderm Research Inc.; Altasciences...RecruitingSolid Tumor | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Small-cell Lung Cancer | Thyroid Cancer | Cutaneous Melanoma | TNBC - Triple-Negative Breast Cancer | Hormone Receptor-positive Breast Cancer | SORT1+ CancersUnited States, Canada
-
Johnson & Johnson Pharmaceutical Research & Development...PharmaMarCompletedPhase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial CarcinomaUterine Neoplasms | Endometrial Neoplasms | Genital Neoplasms, Female Urogenital NeoplasmsUnited States, Canada, Russian Federation, Netherlands